Genefluence's rapid, near-patient PCR test for urinary tract infections in first use at the Royal Hospital Chelsea

Genefluence announced the first use of a rapid test designed to identify UTI-causing bacteria and antibiotic-resistance genes at the point of clinical decision-making. The company says the test can help clinicians select an appropriate antibiotic on the first attempt; the article excerpt provides no accuracy, timing, adoption, or financial figures.